IDEXX (NASDAQ: IDXX) declassifies board, grants 25% special-meeting right
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
IDEXX Laboratories, Inc. reported that shareholders approved key governance changes at the 2026 annual meeting. Amendments to the Amended and Restated Certificate of Incorporation will declassify the Board over three years and move to annual elections for all directors beginning with the 2029 annual meeting.
Shareholders also approved giving investors who own at least 25% of the company’s stock continuously for at least one year the right to require the company to call a special shareholder meeting, subject to conditions in the By-Laws. Three Class II directors were elected through 2029, PricewaterhouseCoopers LLP was ratified as auditor, executive pay received advisory approval, and a separate shareholder proposal on special meeting rights was not approved.
Positive
- None.
Negative
- None.
8-K Event Classification
3 items: 5.03, 5.07, 9.01
3 items
Item 5.03
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Special meeting ownership threshold: 25% of shares
Board declassification start: 2029 annual meeting
Say-on-pay support: 64,399,156 for vs 3,954,026 against
+3 more
6 metrics
Special meeting ownership threshold
25% of shares
Minimum stake, held for at least one year, to require a special meeting
Board declassification start
2029 annual meeting
First meeting when all directors will stand for annual election
Say-on-pay support
64,399,156 for vs 3,954,026 against
Advisory vote on named executive officer compensation
Auditor ratification votes
67,630,771 for vs 5,285,163 against
Ratification of PricewaterhouseCoopers LLP as independent auditor
Shareholder proposal on special meetings
28,179,566 for vs 40,019,951 against
Outcome of shareholder-sponsored special-meeting proposal
Director vote example
64,788,207 for vs 3,589,314 against
Election of director Daniel M. Junius as a Class II director
Key Terms
declassify the Board, Amended and Restated Certificate of Incorporation, Amended and Restated By-Laws, special meeting of shareholders, +1 more
5 terms
declassify the Board financial
"amendments to the Corporation’s Amended and Restated Certificate of Incorporation to (i) declassify the Board over a three-year period"
Declassify the board means changing a company's board of directors from a staggered setup—where only a portion of directors face election each year—to a structure where all directors are elected annually. For investors this matters because it makes the board more directly accountable and responsive, like replacing a multi-year rotating club leadership with yearly elections, and it can speed corporate change or make hostile takeovers easier to pursue.
Amended and Restated Certificate of Incorporation regulatory
"amendments to the Corporation’s Amended and Restated Certificate of Incorporation to (i) declassify the Board"
A company’s amended and restated certificate of incorporation is an updated version of its foundational legal charter that replaces the older document and folds in all changes into one clear copy; it spells out corporate structure, classes of stock, shareholder rights and key governance rules. Investors care because it can change who controls the company, how votes are counted, what claims shareholders have on assets or dividends, and can introduce or remove protections against takeovers—like updating a house title after a major renovation to show who owns what and under what rules.
Amended and Restated By-Laws regulatory
"the Corporation’s By-Laws were amended and restated effective upon the filing of the aforementioned Certificate of Amendment (the “Amended and Restated By-Laws”)"
broker non-votes financial
"For | 28,179,566 Against | 40,019,951 Abstain | 227,294 Broker Non-Votes | 4,524,699"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): May 12, 2026
IDEXX LABORATORIES INC /DE
IDEXX LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
IDEXX LABORATORIES INC /DE
| (State or other jurisdiction | (Commission File Number) | (IRS Employer Identification No.) | ||||||
| of incorporation) | ||||||||
| | |||||||||||
| (Address of principal executive offices) | (ZIP Code) | ||||||||||
0000874716
(Registrant's telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | ||||||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (ß230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (ß240.12b-2 of this chapter). Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
| Item 5.03. | Amendments to Articles of Incorporation or ByLaws; Change in Fiscal Year. | ||||
Certificate of Incorporation
At the 2026 annual meeting of shareholders of IDEXX Laboratories, Inc. (the “Corporation”) held on May 12, 2026 (the “Annual Meeting”), upon the recommendation of the Corporation’s Board of Directors (the “Board”), the Corporation’s shareholders approved amendments to the Corporation’s Amended and Restated Certificate of Incorporation to (i) declassify the Board over a three-year period and provide for the annual election of all directors beginning at the 2029 annual meeting of shareholders and (ii) provide for shareholders owning at least 25% of the shares of the Corporation’s capital stock continuously for at least one year the right to have the Corporation call a special meeting of shareholders, subject to satisfaction of additional terms, conditions, limitations and procedures as set forth in the Corporation’s By-Laws, all as more fully described in the Corporation’s definitive proxy statement for the Annual Meeting (the “Proxy Statement”) filed with the Securities and Exchange Commission on March 27, 2026 (the “Approved Amendments”).
A Certificate of Amendment reflecting the Approved Amendments was filed with the Secretary of State of the State of Delaware and became effective on May 13, 2026. A copy of such Certificate of Amendment is included as Exhibit 3.1 and is incorporated herein by reference.
Amended and Restated By-Laws
On May 13, 2026, pursuant to the Board’s prior approval of certain amendments to our By-Laws, the effectiveness of which were conditioned upon and subject to the filing of a Certificate of Amendment reflecting the Approved Amendments with the Secretary of State of the State of Delaware, the Corporation’s By-Laws were amended and restated effective upon the filing of the aforementioned Certificate of Amendment (the “Amended and Restated By-Laws”). The changes reflected in the Amended and Restated By-Laws include:
•Revisions consistent with the amendments to our Amended and Restated Certificate of Incorporation to declassify the Board;
•Adoption of appropriate terms, conditions, limitations and procedures for requesting a special meeting of shareholders, as more fully described in the Proxy Statement, including as disclosed in Appendix C thereto; and
•Various other technical, ministerial, administrative, conforming and clarifying changes.
The description of the Amended and Restated By-Laws is a summary and is qualified in its entirety by reference to the Amended and Restated By-Laws, which is included as Exhibit 3.2 and is incorporated herein by reference.
| Item 5.07. | Submission of Matters to a Vote of Security Holders. | ||||
On May 12, 2026, the Corporation held its Annual Meeting. At the Annual Meeting, shareholders considered and voted on the following proposals, each of which is described in more detail in the Proxy Statement: (1) the election of Daniel M. Junius, Lawrence D. Kingsley and Sophie V. Vandebroek, PhD, each as a Class II director, for terms expiring at the 2029 annual meeting of shareholders; (2) the ratification of the appointment of PricewaterhouseCoopers LLP as the Corporation's independent registered accounting firm for the current fiscal year; (3) the approval, on an advisory basis, of the compensation of the Corporation's named executive officers; (4) a proposal to amend the Corporation’s Amended and Restated Certificate of Incorporation to declassify the Board; (5) a proposal to amend the Corporation’s Amended and Restated Certificate of Incorporation to provide shareholders owning 25% of the shares of the Corporation's capital stock continuously for at least one year the right to have the Corporation call a special meeting; and (6) a shareholder proposal to give shareholders the ability to call for a special shareholder meeting.
The voting results at the Annual Meeting with respect to each of the matters described above, were as follows:
Proposal One: | Election of Directors. | ||||
| Daniel M. Junius | 64,788,207 | 3,589,314 | 49,290 | 4,524,699 | ||||||||||||||||||||||
Lawrence D. Kingsley | 62,912,441 | 5,466,952 | 47,418 | 4,524,699 | ||||||||||||||||||||||
Sophie V. Vandebroek, PhD | 60,951,897 | 7,383,566 | 91,348 | 4,524,699 | ||||||||||||||||||||||
Proposal Two: | Ratification of Appointment of Independent Registered Public Accounting Firm. | ||||
For | 67,630,771 | ||||
Against | 5,285,163 | ||||
Abstain | 35,576 | ||||
Broker Non-Votes | N/A | ||||
Proposal Three: | Advisory Vote to Approve Executive Compensation. | ||||
For | 64,399,156 | ||||
Against | 3,954,026 | ||||
Abstain | 73,629 | ||||
Broker Non-Votes | 4,524,699 | ||||
Proposal Four: | Amendment to Certificate of Incorporation to Declassify the Board. | ||||
For | 68,306,553 | ||||
Against | 61,880 | ||||
Abstain | 58,378 | ||||
Broker Non-Votes | 4,524,699 | ||||
Proposal Five: | Amendment to Certificate of Incorporation to Provide Shareholders Owning 25% of the Shares of our Capital Stock the Right to Have IDEXX Call a Special Meeting. | ||||
For | 63,934,239 | ||||
Against | 690,137 | ||||
Abstain | 3,802,435 | ||||
Broker Non-Votes | 4,524,699 | ||||
Proposal Six: | Shareholder Proposal to Give Shareholders the Ability to Call for a Special Shareholder Meeting. | ||||
For | 28,179,566 | ||||
Against | 40,019,951 | ||||
Abstain | 227,294 | ||||
Broker Non-Votes | 4,524,699 | ||||
Item 9.01. Financial Statements and Exhibits.
(d) | Exhibits | ||||
3.1 | Certificate of Amendment to the Amended and Restated Certificate of Incorporation of IDEXX Laboratories, Inc., dated May 13, 2026. | ||||
3.2 | Amended and Restated By-Laws of IDEXX Laboratories, Inc., amended through May 13, 2026. | ||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL) | ||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| IDEXX LABORATORIES, INC. | ||||||||
| Date: May 15, 2026 | By: | /s/ Sharon E. Underberg | ||||||
| Sharon E. Underberg | ||||||||
| Executive Vice President, General Counsel and Corporate Secretary | ||||||||
FAQ
How will IDEXX (IDXX) declassify its Board of Directors?
IDEXX will declassify its Board over three years, transitioning from staggered multi-year terms to annual elections. Beginning with the 2029 annual meeting, all directors will stand for election each year, aligning the company with a more frequently elected, single-class board structure.
Which director and auditor proposals passed at the IDEXX (IDXX) 2026 meeting?
All company-backed director and auditor items passed. Shareholders elected Daniel M. Junius, Lawrence D. Kingsley and Sophie V. Vandebroek as Class II directors through the 2029 meeting and ratified PricewaterhouseCoopers LLP as IDEXX’s independent registered public accounting firm for the current fiscal year.